Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors

Introduction: Immune checkpoint inhibitors (ICIs) are recommended for various types of cancer. On the other hand, these ICIs may cause immune-related adverse events (irAEs). Lichen sclerosus (LS) and lichen planus (LP) are two distinct phenotypes of irAEs that occur in a subset of patients treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Alharbi, Ahmad, Khobrani, Attiah, Noor, Afnan, Alghamdi, Waad, Alotaibi, Abdulmalik, Alnuhait, Mohammed, Haseeb, Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819784/
https://www.ncbi.nlm.nih.gov/pubmed/36612904
http://dx.doi.org/10.3390/ijerph20010580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819784/
https://www.ncbi.nlm.nih.gov/pubmed/36612904
http://dx.doi.org/10.3390/ijerph20010580

Ejemplares similares